Silvia Crescioli | Consultant
The Antibody Society

Silvia Crescioli is a Consultant for The Antibody Society and chair of The Antibody Society Communication and Membership Committee. Since 2021 she collaborates to the "Antibodies to watch" editorials in mAbs, reviewing recently approved antibody therapeutics, and forecasting antibody therapeutics marketing application submission as well as approvals that might occur the following year. Dr. Crescioli received her PhD in Biomedical Sciences, Experimental Oncology, from the University of Florence in 2014, followed by eight years of post doc at King's College London in Prof. Karagiannis' Cancer Antibody Discovery & Immunotherapy Group, where she is now a visiting Research Fellow. Her research interests focus on antibody therapeutics development for both cancer and noncancer indications, as well as on different areas of cancer immunology and immunotherapy, including antibody discovery, antibody engineering and glycoengineering.